MedPath

Crestal Bone Level After Allogenic Bone Ring With Simultaneous Dental Implant Placement

Not Applicable
Conditions
Allogenic Bone Ring
Interventions
Procedure: allogenic bone ring
Procedure: autogenous bone ring
Registration Number
NCT03906591
Lead Sponsor
Cairo University
Brief Summary

This trial is aiming to answer a question whether in Patients with severely atrophied, distal mandibular regions, the use of allogenic bone rings with simultaneous dental implants, compared to autogenous bone rings, give successful clinical and radiographic outcomes without donor site morbidity

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
28
Inclusion Criteria
  1. Medically free form any systemic diseases that contraindicate the surgical procedures or affect predictable outcomes and non-smoker subjects.
  2. Atrophic mandibular distal region requiring vertical augmentation.
  3. Good oral hygiene and healthy keratinized mucosa.
Exclusion Criteria
  1. Presence of acute dentoalveolar infection or any pathologic lesions.
  2. Totally edentulous patients and patients requiring massive reconstruction and augmentation procedures.
  3. Patients with history of previously failed augmentation procedures, or failed implant placement at the intended augmentation region.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
allogenic bone ringallogenic bone ring-
autogenous bone ringautogenous bone ring-
Primary Outcome Measures
NameTimeMethod
change in crestal bone heightat 6 months

cone beam computed tomography will be used to measure bone height in millimeters

Secondary Outcome Measures
NameTimeMethod
implant lossafter 1 week, 6 months and after 9 months

signs of implant loss will be evaluated by clinical examination

graft failureafter 1 week, 6 months and after 9 months

signs of graft failure will be evaluated by clinical examination

© Copyright 2025. All Rights Reserved by MedPath